NERVGEN PHARMA CORPNERVGEN PHARMA CORPNERVGEN PHARMA CORP

NERVGEN PHARMA CORP

No trades
See on Supercharts

Price target

4.000.000.00%
The 1 analyst offering 1 year price forecasts for NGEN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to NGEN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NGEN EPS for the last quarter is −0.07 CAD despite the estimation of −0.07 CAD. In the next quarter EPS is expected to reach −0.10 CAD. Track more of NERVGEN PHARMA CORP financials and stay on top of what is up with the company.
According to analysts, NGEN price target is 4.00 CAD with a max estimate of 4.00 CAD and a min estimate of 4.00 CAD. Check if this forecast comes true in a year, meanwhile watch NERVGEN PHARMA CORP stock price chart and keep track of the current situation with NGEN news and stock market news.